A systematic review and meta-analysis of the herbal formula Buzhong Yiqi Tang for stable chronic obstructive pulmonary disease

详细信息    查看全文

• 作者：Yuanbin Chen^a ; ^b ; Johannah Linda Shergis^d ; Lei Wu^a ; ^b ; Xuhua Yu^a ; ^b ; Qigang Zeng^b ; Yinji Xu^b ; Xinfeng Guo^a ; Anthony Lin Zhang^d ; Charlie Changli Xue^a ; ^d ; ^{charlie.xue@rmit.edu.au} ; Lin Lin^a ; ^b ; ^c ; ^{drlinlin620@163.com}
• 关键词：BZYQT ; Buzhong Yiqi Tang ; COPD ; chronic obstructive pulmonary disease ; CENTRAL ; Cochrane Central Register of Controlled Trials ; CBM ; Chinese Biomedical Database ; CNKI ; China National Knowledge Infrastructure ; CQVIP ; ChongQing VIP ; WFMO ; Wanfang Medicine Online ; RCTs ; randomized controlled trials ; GOLD ; Global Initiative for Chronic Obstructive Lung Disease ; 6MWT ; six-minute walking test ; FEV1 ; forced expiratory volume in one second ; FVC ; forced vital capacity ; MIP ; maximum inspiratory pressure
• 刊名：Complementary Therapies in Medicine
• 出版年：2016
• 出版时间：December 2016
• 年：2016
• 卷：29
• 期：Complete
• 页码：94-108
• 全文大小：5958 K
• 卷排序：29

文摘

BZYQT improved clinical symptoms, quality of life, lung function, exercise capacity and reduced respiratory muscle fatigue. BZYQT appeared to be well tolerated by people with COPD. Overall the included studies had risk of bias and results should be interpreted with caution as new studies may change the effect estimates.